NCT03982849View on ClinicalTrials.gov

Comparison of Topical Silymarin With Hydroquinone in the Treatment of Melasma

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

July 15, 2019

Primary Completion Date

December 31, 2019

Study Completion Date

January 15, 2020

Conditions
Melasma
Interventions
DRUG

Hydroquinone 4% Cream

Hydroquinone is tyrosinase inhibitor and thus inhibits melanogenesis.

DRUG

silymarin 0.7% cream

Silymarin is a plant derived flavonoid, extracted from fruits and seeds of milk thistle.

Trial Locations (1)

44000

Islamabad medical and Dental College, Islamabad

All Listed Sponsors
lead

Islamabad Medical and Dental College

OTHER

NCT03982849 - Comparison of Topical Silymarin With Hydroquinone in the Treatment of Melasma | Biotech Hunter | Biotech Hunter